Rescheduling cannabis to Schedule III in the Controlled Substances Act would uphold states rights, allow for cannabis banking and create a path for research, says bill's sponsors
By Michael Bachara
On April 6, Florida Congressman Matt Gaetz (R) and Congressman Darren Soto (D) joined forces in a bipartisan effort to make it easier for ill-patients and scientific and medical researchers to obtain marijuana by introducing H.R. 2020, a federal bill rescheduling marijuana to Schedule III of the Controlled Substances Act. On May 24, California Representative Dana Rohrabacher (R), a member of the Congressional Cannabis Caucus, joined on to co-sponsor the bill.